Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

270.88 +0.88 (+0.33%)

Streaming Delayed Price Updated: 3:49 PM EDT, Sep 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

39 40 Next >

Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership

January 18, 2022

SOURCE: Illumina

Via 3BL Media

Will Earnings Extend The Rally In Value Stocks? ↗

January 17, 2022

US stocks extended their decline from the first week of 2022. Bank earnings disappointed investors. Inflation remained high. Investors questioned the strength of the economy to get through the omicron...

Via Talk Markets

Illumina Named One of America's Most JUST Companies for Third Consecutive Year

January 13, 2022

SOURCE: Illumina

Via 3BL Media

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Analyst Ratings For Illumina ↗

January 11, 2022

Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following ...

Via Benzinga

If You Invested $1,000 When Illumina Acquired Solexa, Here's How Much You'd Have Now ↗

January 12, 2022

Genome sequencing company Illumina Inc (NASDAQ: ILMN) has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006...

Via Benzinga

Promising Developments in Breast Cancer Treatments Ahead in 2022

January 12, 2022

FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 12, 2022 – USA News Group – So far in 2022, there have already been some impressive developments in the battle against...

Via FinancialNewsMedia

Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022 ↗

January 12, 2022

Upgrades Citigroup upgraded the previous rating for Solo Brands Inc (NYSE:

Via Benzinga

Illumina Partners With Agendia to Expand Genomic Testing in Breast Cancer Care

January 12, 2022

SOURCE: Illumina

Via 3BL Media

48 Biggest Movers From Yesterday ↗

January 12, 2022

Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT...

Via Benzinga

Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook ↗

January 11, 2022

Piper says Pacific Bio has a new competitor in Illumina amid plans to launch what looks like a consumable allowing long-read sequencing on its analyzers.

Via Talk Markets

30 Stocks Moving In Tuesday's Mid-Day Session ↗

January 11, 2022

Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year....

Via Benzinga

Illumina Announces New Innovative Partnerships, Along With New Groundbreaking Technologies at 2022 J.P. Morgan Healthcare Conference

January 11, 2022

SOURCE: Illumina

Via 3BL Media

$100 Invested In This Stock 5 Years Ago, Would Be Worth This Much ↗

January 11, 2022

Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 3.83% on an annualized basis. Buying $100 In ILMN: 5 years ago, an investor could have purchased 0.62...

Via Benzinga

The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In ↗

January 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...

Via Benzinga

Why Are Illumina Shares Trading Higher Today? ↗

January 11, 2022

At the J.P. Morgan Healthcare Conference, Illumina Inc (NASDAQ: ILMN) said it expects about $4.517 billion, +39% Y/Y in 2021 revenue after the company logged...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

January 11, 2022

Keybanc cut the price target for Netflix, Inc. (NASDAQ:

Via Benzinga

21 Stocks Moving in Tuesday's Pre-Market Session ↗

January 11, 2022

Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from...

Via Benzinga

A Peek Into The Markets: US Stock Futures Higher Ahead Of Powell ↗

January 11, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped more than 160 points in the previous session. Investors are awaiting earnings...

Via Benzinga

5 Stocks To Watch For January 11, 2022 ↗

January 11, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects TD SYNNEX Corporation (NYSE: SNX) to report quarterly earnings at $2.67 per share on revenue of $...

Via Benzinga

Start Of The Week ↗

January 10, 2022

British property (real estate) stocks fell today.

Via Talk Markets

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 10, 2022

Gainers Inari Medical (NASDAQ:NARI) stock...

Via Benzinga

Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care

January 10, 2022

From Agendia, Inc.

Via Business Wire

Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri® Multi-Cancer Early Detection Test

January 10, 2022

From GRAIL, LLC

Via Business Wire

GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test

January 10, 2022

From GRAIL, LLC

Via Business Wire

Illumina Donates Over $14 Million to Local Communities and Volunteers More Than 6,000 Hours in 2021

January 07, 2022

SOURCE: Illumina

Via 3BL Media

Why Jim Cramer Likes Illumina And Enterprise Products Partners ↗

January 06, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

Illumina Enters Co-Development Partnership with SomaLogic to Help Researchers’ Understanding of Biology and Disease

January 06, 2022

SOURCE: Illumina

Via 3BL Media

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.